19-4658021-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_019107.4(MYDGF):c.506C>T(p.Ser169Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000059 in 1,610,642 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_019107.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MYDGF | NM_019107.4 | c.506C>T | p.Ser169Leu | missense_variant | 6/6 | ENST00000262947.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MYDGF | ENST00000262947.8 | c.506C>T | p.Ser169Leu | missense_variant | 6/6 | 1 | NM_019107.4 | P1 | |
MYDGF | ENST00000599761.5 | c.186+1910C>T | intron_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.000184 AC: 28AN: 152250Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000695 AC: 17AN: 244680Hom.: 0 AF XY: 0.0000755 AC XY: 10AN XY: 132532
GnomAD4 exome AF: 0.0000459 AC: 67AN: 1458392Hom.: 0 Cov.: 30 AF XY: 0.0000414 AC XY: 30AN XY: 725210
GnomAD4 genome AF: 0.000184 AC: 28AN: 152250Hom.: 0 Cov.: 33 AF XY: 0.000148 AC XY: 11AN XY: 74378
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 28, 2024 | The c.506C>T (p.S169L) alteration is located in exon 6 (coding exon 6) of the MYDGF gene. This alteration results from a C to T substitution at nucleotide position 506, causing the serine (S) at amino acid position 169 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at